FDA Inspection 1028749 — South Texas Blood and Tissue Center

South Texas Blood and Tissue Center — FEI 3007003817

The FDA completed an inspection of South Texas Blood and Tissue Center on August 30, 2017 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 30, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Antonio, TX (United States)